EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC 4.0

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021)

C D Prior iD, H Swales, A Kortum, N Reed, M Sharman, D Kelly, A Kent iD, B Glanemann, K Clarke, C Lea iD, E Roberts, N Bommer and 33 more

Journal of Small Animal Practice · 2025

DOI: 10.1111/jsap.13876 ↗

At a glance

Multizentrische Studie in Journal of Small Animal Practice, 2025. Written by C D Prior and 44 co-authors. Institution: Willows Veterinary Centre and Referral Service, Part of Linnaeus Veterinary Limited, Solihull, UK. Major MEDLINE topics: Dog Diseases, Aspergillosis, Nose Diseases. Cited 1 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

A variety of treatment options for sinonasal aspergillosis have been described, encompassing non‐invasive and invasive approaches. To describe the clinical outcomes in dogs treated for sinonasal aspergillosis in the United Kingdom. Materials and Methods A multi‐centre retrospective survey was performed involving 23 referral centres in the United Kingdom from January 2011 to December 2021. Cases were reviewed for first treatment success rates, the number of treatments required and overall clinical remission rates. Different treatment approaches were compared, including rhinoscopic debridement (RD), trephination (TR) and sinusotomy/rhinotomy (SR).

Results

In a cohort of 436 dogs with sinonasal aspergillosis, the most common first treatment modalities were RD (38%) and TR (32%), with SR used in 7% and oral antifungal monotherapy in 3%. The remaining 20% used a mixture of treatments. First treatment remission rate was 55% with SR, 38% with RD, 29% with TR and 31% with the mixed treatment. Overall remission rate was 67% with SR, 81% with RD and 69% with TR and 59% where different treatments were combined. Oral antifungal monotherapy had no successful outcomes at any time point. Complete debridement significantly improved remission rates of first treatments (54% vs. 21%, P = 0.003). Adverse effects were reported in 24% of cases, most commonly in SR and TR groups. Clinical Significance Rhinoscopic debridement and trephination remain the predominant treatment options for SNA in UK referral practices, with similar overall clinical remission rates. The degree of debridement significantly influences treatment outcomes, with rhinoscopic debridement in combination with topical antifungals showing the highest success rates.

Subjects

MeSH terms (MEDLINE)

Dog DiseasesAspergillosisNose DiseasesAnimalsDogsRetrospective StudiesUnited KingdomTreatment OutcomeAntifungal AgentsMaleFemaleDebridement

Substances

Antifungal Agents

Authors and institutions

  • Willows Veterinary Centre and Referral Service, Part of Linnaeus Veterinary Limited, Solihull, UK.
  • Bridge Referrals, Boldon, UK.
  • Department of Veterinary Medicine, Cambridge Veterinary School, Cambridge, UK.
  • Veterinary Specialists Scotland, Livingston, UK.
  • VetCt, Cambridge, UK.
  • Southern Counties Veterinary Specialists, Ringwood, UK.

ORCID profiles: C D Prior, A Kent, C Lea, S J Fowlie

Cite

APA

Prior, C. D., Swales, H., Kortum, A., Reed, N., Sharman, M., Kelly, D., Kent, A., Glanemann, B., Clarke, K., Lea, C., Roberts, E., Bommer, N., Rutherford, L., Tamborini, A., Murphy, K., Batchelor, D. J., Calleja, S., Burrow, R., Jamieson, P. M., …, & Allerton, F. (2025). Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021). Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13876

Vancouver

Prior CD, Swales H, Kortum A, Reed N, Sharman M, Kelly D, et al. Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021). Journal of Small Animal Practice. 2025. doi:10.1111/jsap.13876

BibTeX
@article{Prior2025,
  author = {Prior, C D and Swales, H and Kortum, A and Reed, N and Sharman, M and Kelly, D and Kent, A and Glanemann, B and Clarke, K and Lea, C and Roberts, E and Bommer, N and Rutherford, L and Tamborini, A and Murphy, K and Batchelor, D J and Calleja, S and Burrow, R and Jamieson, P M and Piazza, C and Best, M and Calvo Saiz, I and Elgueta, I and Fowlie, S J and Shales, C and Gil Morales, C and Lopez, E and Borgonovi, S and Keane, M and Kennils, J and Izaguirre, E and Hernandez-Perello, M and Lau, N and Paul, A and Ridyard, A and Shelton, E and Farges, A and Specchia, G and Espada, L and Spence, S and Hrovat, A and Van den Steen, N and Tappin, S and Sparks, T H and Allerton, F},
  title = {Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021)},
  journal = {Journal of Small Animal Practice},
  year = {2025},
  doi = {10.1111/jsap.13876}
}
Start for free →